Cargando…
Tumour cell invasiveness and response to chemotherapeutics in adipocyte invested 3D engineered anisotropic collagen scaffolds
Breast cancers are highly heterogeneous and their metastatic potential and response to therapeutic drugs is difficult to predict. A tool that could accurately gauge tumour invasiveness and drug response would provide a valuable addition to the oncologist’s arsenal. We have developed a 3-dimensional...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107500/ https://www.ncbi.nlm.nih.gov/pubmed/30139956 http://dx.doi.org/10.1038/s41598-018-30107-3 |
_version_ | 1783349974555164672 |
---|---|
author | Hume, Robert D. Pensa, Sara Brown, Elizabeth J. Kreuzaler, Peter A. Hitchcock, Jessica Husmann, Anke Campbell, Jonathan J. Lloyd-Thomas, Annabel O. Cameron, Ruth E. Watson, Christine J. |
author_facet | Hume, Robert D. Pensa, Sara Brown, Elizabeth J. Kreuzaler, Peter A. Hitchcock, Jessica Husmann, Anke Campbell, Jonathan J. Lloyd-Thomas, Annabel O. Cameron, Ruth E. Watson, Christine J. |
author_sort | Hume, Robert D. |
collection | PubMed |
description | Breast cancers are highly heterogeneous and their metastatic potential and response to therapeutic drugs is difficult to predict. A tool that could accurately gauge tumour invasiveness and drug response would provide a valuable addition to the oncologist’s arsenal. We have developed a 3-dimensional (3D) culture model that recapitulates the stromal environment of breast cancers by generating anisotropic (directional) collagen scaffolds seeded with adipocytes and culturing tumour fragments therein. Analysis of tumour cell invasion in the presence of various therapeutic drugs, by immunofluorescence microscopy coupled with an optical clearing technique, demonstrated the utility of this approach in determining both the rate and capacity of tumour cells to migrate through the stroma while shedding light also on the mode of migration. Furthermore, the response of different murine mammary tumour types to chemotherapeutic drugs could be readily quantified. |
format | Online Article Text |
id | pubmed-6107500 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-61075002018-08-28 Tumour cell invasiveness and response to chemotherapeutics in adipocyte invested 3D engineered anisotropic collagen scaffolds Hume, Robert D. Pensa, Sara Brown, Elizabeth J. Kreuzaler, Peter A. Hitchcock, Jessica Husmann, Anke Campbell, Jonathan J. Lloyd-Thomas, Annabel O. Cameron, Ruth E. Watson, Christine J. Sci Rep Article Breast cancers are highly heterogeneous and their metastatic potential and response to therapeutic drugs is difficult to predict. A tool that could accurately gauge tumour invasiveness and drug response would provide a valuable addition to the oncologist’s arsenal. We have developed a 3-dimensional (3D) culture model that recapitulates the stromal environment of breast cancers by generating anisotropic (directional) collagen scaffolds seeded with adipocytes and culturing tumour fragments therein. Analysis of tumour cell invasion in the presence of various therapeutic drugs, by immunofluorescence microscopy coupled with an optical clearing technique, demonstrated the utility of this approach in determining both the rate and capacity of tumour cells to migrate through the stroma while shedding light also on the mode of migration. Furthermore, the response of different murine mammary tumour types to chemotherapeutic drugs could be readily quantified. Nature Publishing Group UK 2018-08-23 /pmc/articles/PMC6107500/ /pubmed/30139956 http://dx.doi.org/10.1038/s41598-018-30107-3 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Hume, Robert D. Pensa, Sara Brown, Elizabeth J. Kreuzaler, Peter A. Hitchcock, Jessica Husmann, Anke Campbell, Jonathan J. Lloyd-Thomas, Annabel O. Cameron, Ruth E. Watson, Christine J. Tumour cell invasiveness and response to chemotherapeutics in adipocyte invested 3D engineered anisotropic collagen scaffolds |
title | Tumour cell invasiveness and response to chemotherapeutics in adipocyte invested 3D engineered anisotropic collagen scaffolds |
title_full | Tumour cell invasiveness and response to chemotherapeutics in adipocyte invested 3D engineered anisotropic collagen scaffolds |
title_fullStr | Tumour cell invasiveness and response to chemotherapeutics in adipocyte invested 3D engineered anisotropic collagen scaffolds |
title_full_unstemmed | Tumour cell invasiveness and response to chemotherapeutics in adipocyte invested 3D engineered anisotropic collagen scaffolds |
title_short | Tumour cell invasiveness and response to chemotherapeutics in adipocyte invested 3D engineered anisotropic collagen scaffolds |
title_sort | tumour cell invasiveness and response to chemotherapeutics in adipocyte invested 3d engineered anisotropic collagen scaffolds |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107500/ https://www.ncbi.nlm.nih.gov/pubmed/30139956 http://dx.doi.org/10.1038/s41598-018-30107-3 |
work_keys_str_mv | AT humerobertd tumourcellinvasivenessandresponsetochemotherapeuticsinadipocyteinvested3dengineeredanisotropiccollagenscaffolds AT pensasara tumourcellinvasivenessandresponsetochemotherapeuticsinadipocyteinvested3dengineeredanisotropiccollagenscaffolds AT brownelizabethj tumourcellinvasivenessandresponsetochemotherapeuticsinadipocyteinvested3dengineeredanisotropiccollagenscaffolds AT kreuzalerpetera tumourcellinvasivenessandresponsetochemotherapeuticsinadipocyteinvested3dengineeredanisotropiccollagenscaffolds AT hitchcockjessica tumourcellinvasivenessandresponsetochemotherapeuticsinadipocyteinvested3dengineeredanisotropiccollagenscaffolds AT husmannanke tumourcellinvasivenessandresponsetochemotherapeuticsinadipocyteinvested3dengineeredanisotropiccollagenscaffolds AT campbelljonathanj tumourcellinvasivenessandresponsetochemotherapeuticsinadipocyteinvested3dengineeredanisotropiccollagenscaffolds AT lloydthomasannabelo tumourcellinvasivenessandresponsetochemotherapeuticsinadipocyteinvested3dengineeredanisotropiccollagenscaffolds AT cameronruthe tumourcellinvasivenessandresponsetochemotherapeuticsinadipocyteinvested3dengineeredanisotropiccollagenscaffolds AT watsonchristinej tumourcellinvasivenessandresponsetochemotherapeuticsinadipocyteinvested3dengineeredanisotropiccollagenscaffolds |